Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Smith & Nephew (SNN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Smith & Nephew (SNN) over the last 17 years, with Q2 2025 value amounting to $676.0 million.

  • Smith & Nephew's Cash & Equivalents rose 1901.41% to $676.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $676.0 million, marking a year-over-year increase of 1901.41%. This contributed to the annual value of $545.0 million for FY2024, which is 8046.36% up from last year.
  • Per Smith & Nephew's latest filing, its Cash & Equivalents stood at $676.0 million for Q2 2025, which was up 1901.41% from $545.0 million recorded in Q4 2024.
  • Over the past 5 years, Smith & Nephew's Cash & Equivalents peaked at $1.8 billion during Q4 2021, and registered a low of $302.0 million during Q4 2023.
  • Over the past 5 years, Smith & Nephew's median Cash & Equivalents value was $556.5 million (recorded in 2024), while the average stood at $698.7 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 58132.3% in 2021, then plummeted by 8001.14% in 2022.
  • Quarter analysis of 5 years shows Smith & Nephew's Cash & Equivalents stood at $1.8 billion in 2021, then crashed by 80.01% to $350.0 million in 2022, then decreased by 13.71% to $302.0 million in 2023, then skyrocketed by 80.46% to $545.0 million in 2024, then increased by 24.04% to $676.0 million in 2025.
  • Its Cash & Equivalents stands at $676.0 million for Q2 2025, versus $545.0 million for Q4 2024 and $568.0 million for Q2 2024.